Note that some links may require subscriptions.
Reaction to Purdue’s promise to halt OxyContin marketing to prescribers: “20 years late” and “a little bit not honest.” (NPR)
FDA advisory committees today will review a new indication for liposomal bupivacaine (Exparel) and a new hydrocodone product formulated with promethazine to limit nausea and vomiting.
One lot of Apace Packaging’s generic acyclovir 400 mg in 50-unit blister packs has been recalled, the FDA said, because some tablets may actually be torsemide 20 mg, a diuretic.
Parents of a 3-year-old girl in Muncie, Ind., who died of the flu said she wasn’t vaccinated because they’d been told that once the flu was going around, it didn’t matter whether you were vaccinated or not. (ABC News)
Kidney stones appear to be on the increase in the U.S. (CNN)
On the other hand, American women’s fertility is dropping and likely to fall further. (The New York Times)
Shortage warning: Bayer says “temporary supply limitations” may hit several older drugs made at its main German factory after an FDA inspection turned up violations.
What’s old becomes new: researchers look in dirt for novel antibiotics, just as they did in the 1950s. (The Washington Post)
Twin toddlers joined at the chest and abdomen were successfully separated at a Houston hospital. (9News.com)
In men with metastatic melanoma, obesity was linked to longer survival. (The New York Times)
Scientists have chosen a close-knit community in which to examine influenza’s spread: a college dorm. (NBC News)
Morning Break is a daily guide to what’s new and interesting on the Web for healthcare professionals, powered by the MedPage Today community. Got a tip? Send it to us: MPT_editorial@everydayhealthinc.com.